共 10 条
- [1] Case History: Kalydeco® (VX-770, Ivacaftor), a CFTR Potentiator for the Treatment of Patients with Cystic Fibrosis and the G551D-CFTR Mutation ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 49, 2014, 49 : 383 - 398
- [6] ATP-Dependent Signaling in Simulations of a Revised Model of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) JOURNAL OF PHYSICAL CHEMISTRY B, 2019, 123 (15): : 3177 - 3188
- [9] Mutating the Conserved Q-loop Glutamine 1291 Selectively Disrupts Adenylate Kinase-dependent Channel Gating of the ATP-binding Cassette (ABC) Adenylate Kinase Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Reduces Channel Function in Primary Human Airway Epithelia JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (22) : 14140 - 14153
- [10] Discovery of N-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-lH-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High Extent JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (04) : 1425 - 1435